emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Sinclair Pharma / Groupe CS Dermatologie

No EMAT : 16401
Announced Date : 13/03/2006
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Sinclair Pharma

Target : Groupe CS Dermatologie
Country : France
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Originally established in 1986 as a joint venture between Didier Rase and Sanofi and incorporated the latter’s prescription dermatology business in 1991 > Manufactures and distributes of topical...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Personal Products » = 134
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
17/01/2005 Recordati Branded Pharmaceutical Business of Merckle Germany ** 16370
11/04/2005 Kalina Concern Dr Scheller Cosmetics Germany ** 16368

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report